Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Cristina Vincent"'
Autor:
David M. Findlay, Cristina Vincent, Masakazu Kogawa, Renee T. Ormsby, Howard A. Morris, Paul H. Anderson, Gerald J. Atkins
Publikováno v:
Endocrinology. 151:4613-4625
The extrarenal synthesis of 1α,25 dihydroxyvitamin D3 (1,25D) has been demonstrated in a number of cell types including osteoblasts and cells of the monocyte/macrophage lineage. The skeleton appears responsive to serum levels of the 1,25D precursor,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d600d9281858ed3a2169b84a2f7c1f6a
https://doi.org/10.1210/en.2010-0334
https://doi.org/10.1210/en.2010-0334
Autor:
Cristina Vincent, Sally Martin, Gerald J. Atkins, Andrew C.W. Zannettino, Timothy S. Zheng, Sharon A. Williams, Stan Gronthos
Publikováno v:
British Journal of Haematology. 150:373-376
Sharon A. Williams, Sally K. Martin, Cristina Vincent, Stan Gronthos, Timothy Zheng, Gerald J. Atkins and Andrew C. W. Zannettino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d1840084ff33b7c9ca769e4bdfc717d
https://doi.org/10.1111/j.1365-2141.2010.08201.x
https://doi.org/10.1111/j.1365-2141.2010.08201.x
Autor:
Katie J. Welldon, Andrew C.W. Zannettino, Gerald J. Atkins, Cristina Vincent, David M. Findlay, Peter D. O’Loughlin, Paul H. Anderson, Howard A. Morris
Publikováno v:
Bone. 40:1517-1528
Circulating 1 alpha,25-dihydroxyvitamin D(3) (1,25D) derives from renal conversion of 25-hydroxyvitamin D(3) (25D), by the 25D 1 alpha-hydroxylase (CYP27B1). Blood 25D levels, but not 1,25D levels, are the best indicator of vitamin D status and predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ae4c3532a3e7b7244071ce232b9526
https://doi.org/10.1016/j.bone.2007.02.024
https://doi.org/10.1016/j.bone.2007.02.024
Autor:
Hisham F. Bahmad, Lauren Ramesar, Cecilia Nosti, Gameli Anthonio, Carole Brathwaite, Cristina Vincentelli, Amilcar A. Castellano-Sánchez, Robert Poppiti
Publikováno v:
Diseases, Vol 12, Iss 1, p 2 (2023)
The Journal retracts the article, Histopathologic Findings Associated with Miller–Dieker Syndrome: An Autopsy Report [...]
Externí odkaz:
https://doaj.org/article/a769b034080a47a485a8248bdda83b3b
Autor:
Kacper A. Walentynowicz, Dalit Engelhardt, Simona Cristea, Shreya Yadav, Ugoma Onubogu, Roberto Salatino, Melanie Maerken, Cristina Vincentelli, Aashna Jhaveri, Jacob Geisberg, Thomas O. McDonald, Franziska Michor, Michalina Janiszewska
Publikováno v:
Cell Reports, Vol 42, Iss 3, Pp 112235- (2023)
Summary: Glioblastoma (GBM) is the most aggressive brain tumor, with a median survival of ∼15 months. Targeted approaches have not been successful in this tumor type due to the large extent of intratumor heterogeneity. Mosaic amplification of oncog
Externí odkaz:
https://doaj.org/article/60308efb3c604892b7520a2072a1e78d
Autor:
Sharon A, Williams, Sally K, Martin, Cristina, Vincent, Stan, Gronthos, Timothy, Zheng, Gerald J, Atkins, Andrew C W, Zannettino
Publikováno v:
British journal of haematology. 150(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6aa5c393dfec5e1478f00115ddd8b818
https://pubmed.ncbi.nlm.nih.gov/20408838
https://pubmed.ncbi.nlm.nih.gov/20408838
Autor:
Cristina Vincent, Gerald J. Atkins, Nicola L. Fazzalari, Timothy S. Zheng, Katie J. Welldon, David R. Haynes, Andreas Evdokiou, Asiri R. Wijenayaka, David M. Findlay
We have recently shown that TNF‐related weak inducer of apoptosis (TWEAK) is a mediator of inflammatory bone remodeling. The aim of this study was to investigate the role of TWEAK in modulating human osteoblast activity, and how TWEAK and TNFα mig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a9306e9c4c107ff08f7dbe29a9ed32
https://hdl.handle.net/1959.8/135393
https://hdl.handle.net/1959.8/135393
Autor:
Gerald J. Atkins, Vasilios Liapis, Peter Diamond, David M. Findlay, Cristina Vincent, Agatha Labrinidis, Andrew C.W. Zannettino, Irene Zinonos, Shelley Hay, Sally Martin, Vladimir Ponomarev, Andreas Evdokiou, Natalie A. Sims
Purpose: Multiple myeloma is an incurable disease, for which the development of new therapeutic approaches is required. Here, we report on the efficacy of recombinant soluble Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc5dea38bf263e0592ce8d5031ad1ab
https://hdl.handle.net/1959.8/126408
https://hdl.handle.net/1959.8/126408
Autor:
Helen E. MacLean, Julie F. McManus, Andrew G. Turner, David M. Findlay, Alison J. Moore, Vaida Glatt, Cristina Vincent, Howard A. Morris, Mary L. Bouxsein, Cathy Ma, Jeffrey D Zajac, Francisca Tjahyono, Gerald J. Atkins, W.S. Maria Chiu, Rachel A Davey, Paul H. Anderson
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 23(8)
It is well established that calcitonin is a potent inhibitor of bone resorption; however, a physiological role for calcitonin acting through its cognate receptor, the calcitonin receptor (CTR), has not been identified. Data from previous genetically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6aa60d7a1709478dce3a9720abe1b10
https://pubmed.ncbi.nlm.nih.gov/18627265
https://pubmed.ncbi.nlm.nih.gov/18627265
Publikováno v:
Journal of bone and mineral metabolism. 27(1)
Osteoclasts are the unique cell type capable of resorbing bone. The discovery of the TNF-ligand family member, RANKL, has allowed more reliable study of these important cells. The mouse monocytic cell line, RAW 264.7, has been shown to readily differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d66a28e6c423420c268558719a2066ae
https://pubmed.ncbi.nlm.nih.gov/19057837
https://pubmed.ncbi.nlm.nih.gov/19057837